Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Khuri

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Annals of Internal Medicine|September 1, 1975
Editorial: A new "heroin epidemic"?M J Kreek, E Khuri, H Joseph
Journal of the Irish Medical Association|June 15, 1974
An unusual tumour of the neck and superior mediastinumP E Kiely, M S Kaplan, T S Li, et al.
Progress in Clinical and Biological Research|January 1, 1990
Immune status of unselected methadone maintained former heroin addictsM J Kreek, E Khuri, N Flomenberg, et al.
British Journal of Addiction|September 1, 1990
Metyrapone-induced withdrawal symptomsJ A Kennedy, N Hartman, R Sbriglio, et al.
NIDA Research Monograph|January 1, 1991
Metyrapone-induced withdrawal symptoms: symptoms in methadone-maintained patientsJ A Kennedy, N Hartman, R Sbriglio, et al.
Alcoholism, Clinical and Experimental Research|January 1, 1983
Alcohol use in youthful methadone-maintained former heroin addicts: liver impairment and treatment outcomeN Hartman, M J Kreek, A Ross, et al.
Journal of Substance Abuse Treatment|January 1, 1990
Working with heroin sniffers: clinical issues in preventing drug injectionC Casriel, D C Des Jarlais, R Rodriguez, et al.
Addiction (Abingdon, England)|December 22, 1999
Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccinationL Borg, E Khuri, A Wells, et al.
Israel Journal of Medical Sciences|September 1, 1994
Effects of the opioid antagonist naloxone on human natural killer cell activity in vitroM O Adelson, D M Novick, E Khuri, et al.
NIDA Research Monograph|January 1, 1986
Long-term followup studies of the medical status of adolescent former heroin addicts in chronic methadone maintenance treatment: liver disease and immune statusM J Kreek, E Khuri, L Fahey, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annals of Internal Medicine|September 1, 1975
Editorial: A new "heroin epidemic"?M J Kreek, E Khuri, H Joseph
Journal of the Irish Medical Association|June 15, 1974
An unusual tumour of the neck and superior mediastinumP E Kiely, M S Kaplan, T S Li, et al.
Progress in Clinical and Biological Research|January 1, 1990
Immune status of unselected methadone maintained former heroin addictsM J Kreek, E Khuri, N Flomenberg, et al.
British Journal of Addiction|September 1, 1990
Metyrapone-induced withdrawal symptomsJ A Kennedy, N Hartman, R Sbriglio, et al.
NIDA Research Monograph|January 1, 1991
Metyrapone-induced withdrawal symptoms: symptoms in methadone-maintained patientsJ A Kennedy, N Hartman, R Sbriglio, et al.
Alcoholism, Clinical and Experimental Research|January 1, 1983
Alcohol use in youthful methadone-maintained former heroin addicts: liver impairment and treatment outcomeN Hartman, M J Kreek, A Ross, et al.
Journal of Substance Abuse Treatment|January 1, 1990
Working with heroin sniffers: clinical issues in preventing drug injectionC Casriel, D C Des Jarlais, R Rodriguez, et al.
Addiction (Abingdon, England)|December 22, 1999
Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccinationL Borg, E Khuri, A Wells, et al.
Israel Journal of Medical Sciences|September 1, 1994
Effects of the opioid antagonist naloxone on human natural killer cell activity in vitroM O Adelson, D M Novick, E Khuri, et al.
NIDA Research Monograph|January 1, 1986
Long-term followup studies of the medical status of adolescent former heroin addicts in chronic methadone maintenance treatment: liver disease and immune statusM J Kreek, E Khuri, L Fahey, et al.
Pageof 1